268 related articles for article (PubMed ID: 23671798)
1. Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer.
Leick MB; Shoff CJ; Wang EC; Congress JL; Gallicano GI
Am J Stem Cells; 2012; 1(1):59-74. PubMed ID: 23671798
[TBL] [Abstract][Full Text] [Related]
2. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
[TBL] [Abstract][Full Text] [Related]
3. Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer.
Cui H
Dis Markers; 2007; 23(1-2):105-12. PubMed ID: 17325430
[TBL] [Abstract][Full Text] [Related]
4. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM
Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102
[TBL] [Abstract][Full Text] [Related]
5. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
Bjornsson HT; Brown LJ; Fallin MD; Rongione MA; Bibikova M; Wickham E; Fan JB; Feinberg AP
J Natl Cancer Inst; 2007 Aug; 99(16):1270-3. PubMed ID: 17686827
[TBL] [Abstract][Full Text] [Related]
7. IGF2 loss of imprinting enhances colorectal cancer stem cells pluripotency by promoting tumor autophagy.
Gao T; Liu X; He B; Pan Y; Wang S
Aging (Albany NY); 2020 Nov; 12(21):21236-21252. PubMed ID: 33173015
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.
Bhusari S; Yang B; Kueck J; Huang W; Jarrard DF
Prostate; 2011 Nov; 71(15):1621-30. PubMed ID: 21432864
[TBL] [Abstract][Full Text] [Related]
9. Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells.
Vu TH; Nguyen AH; Hoffman AR
Hum Mol Genet; 2010 Mar; 19(5):901-19. PubMed ID: 20015958
[TBL] [Abstract][Full Text] [Related]
10. Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells.
Hofmann WK; Takeuchi S; Frantzen MA; Hoelzer D; Koeffler HP
Exp Hematol; 2002 Apr; 30(4):318-23. PubMed ID: 11937266
[TBL] [Abstract][Full Text] [Related]
11. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of primary lung cancer in the central China region.
Zhang M; Wu CH; Zhu XL; Wang YJ
Asian Pac J Cancer Prev; 2014; 15(18):7799-803. PubMed ID: 25292066
[TBL] [Abstract][Full Text] [Related]
12. Loss of
Damaschke NA; Yang B; Bhusari S; Avilla M; Zhong W; Blute ML; Huang W; Jarrard DF
Cancer Res; 2017 Oct; 77(19):5236-5247. PubMed ID: 28775169
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2.
Sasaki J; Konishi F; Kawamura YJ; Kai T; Takata O; Tsukamoto T
Int J Cancer; 2006 Jul; 119(1):80-3. PubMed ID: 16432831
[TBL] [Abstract][Full Text] [Related]
14. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications.
Belharazem D; Magdeburg J; Berton AK; Beissbarth L; Sauer C; Sticht C; Marx A; Hofheinz R; Post S; Kienle P; Ströbel P
J Gastroenterol; 2016 Oct; 51(10):971-84. PubMed ID: 26984550
[TBL] [Abstract][Full Text] [Related]
16. Aging and cancer-related loss of insulin-like growth factor 2 imprinting in the mouse and human prostate.
Fu VX; Dobosy JR; Desotelle JA; Almassi N; Ewald JA; Srinivasan R; Berres M; Svaren J; Weindruch R; Jarrard DF
Cancer Res; 2008 Aug; 68(16):6797-802. PubMed ID: 18701505
[TBL] [Abstract][Full Text] [Related]
17. Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.
Cheng YW; Idrees K; Shattock R; Khan SA; Zeng Z; Brennan CW; Paty P; Barany F
Int J Cancer; 2010 Aug; 127(3):568-77. PubMed ID: 19957330
[TBL] [Abstract][Full Text] [Related]
18. Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines.
Li T; Chen H; Li W; Cui J; Wang G; Hu X; Hoffman AR; Hu J
Hum Mol Genet; 2014 Jan; 23(1):117-28. PubMed ID: 23962719
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition.
Cruz-Correa M; Cui H; Giardiello FM; Powe NR; Hylind L; Robinson A; Hutcheon DF; Kafonek DR; Brandenburg S; Wu Y; He X; Feinberg AP
Gastroenterology; 2004 Apr; 126(4):964-70. PubMed ID: 15057734
[TBL] [Abstract][Full Text] [Related]
20. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2.
Cui H; Onyango P; Brandenburg S; Wu Y; Hsieh CL; Feinberg AP
Cancer Res; 2002 Nov; 62(22):6442-6. PubMed ID: 12438232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
